Bloom Burton lowered its rating on YM BioSciences (NYSE: YMI ) from Buy to Hold with a $2.95 price target. Bloom Burton noted, "We are updating our price target to US$2.95 and rating to Hold after last week's announcement of the acquisition of YM by Gilead Sciences (NASDAQ:
